XR Securities’s Celgene Corp CELG Stock Holding History

XR Securities’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,600	Closed	-$19K	–	337
2019 Q3	$19K	Sell	16,600 -10,700	-39%	-$1.02M	﹤0.01%	195
2019 Q2	$62K	Sell	27,300 -38,700	-59%	-$3.67M	0.01%	170
2019 Q1	$61K	Buy	66,000 +39,300	+147%	+$3.44M	0.01%	194
2018 Q4	$274K	Buy	26,700 +6,300	+31%	+$465K	0.12%	111
2018 Q3	$125K	Buy	+20,400	New	+$1.8M	0.03%	192

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

XR Securities's CELG Position: Q4 2019 in Review

XR Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,653 shares — an estimated $561K sold.

XR Securities first reported a position in CELG in Q2 2018 and held it in 5 quarters. The position peaked at $1.05M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

XR Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
XR Securities sold 5,653 Celgene Corp shares in Q4 2019, an estimated $561K.
XR Securities first reported a position in Celgene Corp in Q2 2018 and held it in 5 quarters.
XR Securities's Celgene Corp position peaked at $1.05M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on XR Securities's 13F filing for Q4 2019, filed 6 Jan 2020.